MMR (maternal deaths per 100,000 live births) and 95% confidence limits by urban and rural areas, PDHS 2007 and PMMS 2019. by Farid Midhet (17403945)

Subjects:

Comparison of biological and socioeconomic risk factors of maternal mortality, in Pakistan (PDHS 2007 and PMMS 2019) (see note 1). by Farid Midhet (17403945)

Subjects:

Comparison of the association between maternal mortality in rural areas and distance to a hospital providing CEmONC and distance to public transport, Pakistan 2007 and 2019 (see no... by Farid Midhet (17403945)

Subjects:

Evaluation of risk model. by Yajia Chen (20685780)

Subjects:

Mean mesenteric, retroperitoneal, pericardial, and total visceral adipose tissue weights (in grams) upon completion of the experiment. by Elsie D. Oduor (22521785)

Subjects:

Line graph illustrating mean body weight (in grams) at weekly intervals during the induction phase. by Elsie D. Oduor (22521785)

Subjects:

Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

Subjects:

MMR (maternal deaths per 100,000 live births) and 95% confidence limits, PDHS 2007 and PMMS 2019. by Farid Midhet (17403945)

Subjects:

Line graph illustrating mean body weight (in grams) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

Subjects:

Relationship of risk score with immune status. by Yajia Chen (20685780)

Subjects:

Mean lipid profile (mmol/L) upon completion of the experimental period. by Elsie D. Oduor (22521785)

Subjects:

Data processing and predictive model construction. by Yajia Chen (20685780)

Subjects:

SPSS data analysis files. by Farid Midhet (17403945)

Subjects:

Line graph illustrating mean food intake (g) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

Subjects:

Drug concentrations for constructing a normal astrocyte cuproptosis model and expression of high-risk CRLs and co-expression CRGs in the human astrocyte cuproptosis model. by Yajia Chen (20685780)

Subjects:

Mean blood glucose responses (mmol/L) to an oral blood glucose bolus 2g/kg during a 120-minute period and mean area under the curve (mmol/L.min) during the oral blood glucose toler... by Elsie D. Oduor (22521785)

Subjects:

Representative liver histology of normal control (A), low-dose Olanzapine (B), negative control (C), test (D), and positive control (E) groups (Hematoxylin and Eosin stain, ×400 ma... by Elsie D. Oduor (22521785)

Subjects:

EF-24 treatment significantly reduces cell viability in leukemia cell lines. by Ajeet P. Singh (22298432)

Subjects:

Training impact on electrical properties of P3 lumbar MNs. Rin: input resistance. Rheobase: lowest intensity of current injected in MNs to elicit an action potential (AP). AP threshold: voltage measured at the foot of the AP. AP amplitude: measured between the resting membrane potential and the AP peak. AP half width: time spent by the potential > 50% of the AP maximum amplitude. AP rise time: time spent by the potential between 10% and 90% of the AP maximum amplitude. AP half decay time: time spent by the potential between the AP maximum amplitude and the 50% decreasing amplitude. ADP: after-depolarization potential.... by Camille Quilgars (21156495)

“…AP half decay time: time spent by the potential between the AP maximum amplitude and the 50% decreasing amplitude. ADP: after-depolarization potential. …”

IRE1 silencing downregulates cell cycle genes and engages TP53 and specific CDK inhibitors. by Iratxe Zuazo-Gaztelu (21071939)

Subjects: